Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties to Improve Prostate Cancer Therapy
Metadata only
Datum
2018-06Typ
- Journal Article
Publikationsstatus
publishedExterne Links
Zeitschrift / Serie
Molecular PharmaceuticsBand
Seiten / Artikelnummer
Verlag
American Chemical SocietyThema
177Lu; albumin binder; prostate cancer; PSMA ligands; radionuclide therapyOrganisationseinheit
03688 - Schibli, Roger / Schibli, Roger